Source: BioPortfolio

Gilupi: New Study Extends Application Range of GILUPI CellCollector Towards Quantitative Analysis of Gene Expression in Circulating Tumor Cells

GILUPI announces the publication of a peer reviewed study about a new and promising mRNAbased assay that allows detection and quantification of clinically relevant prostate and pancreas cancer markers in circulating tumor cells CTCs. CTCs are a surrogate m...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Christian Jurinke's photo - CEO of Gilupi

CEO

Christian Jurinke

CEO Approval Rating

70/100

Read more